The study aims to assess the viability of weekly extended-release buprenorphine for treating opioid use disorder during pregnancy.
Examined the use of extended-release buprenorphine for opioid use disorder treatment in pregnant patients.
Analyzed maternal and infant health outcomes associated with the treatment.
Demonstrated positive effects of treatment on maternal and infant health during pregnancy.
Supported the use of weekly dosing for managing opioid use disorder in pregnant women.
Abstract
A landmark study supporting weekly extended‐release buprenorphine for opioid use disorder (OUD) treatment during pregnancy was published in JAMA Internal Medicine online March 16.